Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
Crossref DOI link: https://doi.org/10.1007/s12664-015-0604-1
Published Online: 2015-11-05
Published Print: 2015-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
John, Anil
Al Kaabi, Saad
Doiphode, Sanjay
Chandra, Prem
Sharma, Manik
Babu, Ragesh
Yacoub, Rafie
Derbala, Moutaz
Funding for this research was provided by:
Hamad Medical Corporation (QA) (12014/12)
Text and Data Mining valid from 2015-09-01